Search Results - "Fabisiak, Adam"

Rescue therapy with upadacitinib in severe Crohn's disease.

Authors: Caban, Miłosz Fabisiak, Adam Dudek, Patrycja et al.

Source: Gastroenterology Review / Przegląd Gastroenterologiczny. 2026, Vol. 21 Issue 2, p222-227. 6p.

Advanced Combination Therapy in Inflammatory Bowel Disease: What Does the Future Hold?

Authors: Eder, Piotr Fabisiak, Adam Zatorski, Hubert et al.

Source: BioDrugs. May2026, Vol. 40 Issue 3, p361-380. 20p.

Advancements in dual biologic therapy for inflammatory bowel diseases: efficacy, safety, and future directions.

Authors: Fabisiak, Adam Caban, Miłosz Dudek, Patrycja et al.

Source: Therapeutic Advances in Gastroenterology. 1/2/2025, Vol. 18, p1-17. 17p.

Novel selective agonist of GPR18, PSB‐KK‐1415 exerts potent anti‐inflammatory and anti‐nociceptive activities in animal models of intestinal inflammation and inflammatory pain.

Authors: Fabisiak, Adam Fabisiak, Natalia Mokrowiecka, Anna et al.

Source: Neurogastroenterology & Motility. Mar2021, Vol. 33 Issue 3, p1-10. 10p.

Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis.

Authors: Fabisiak, Adam Włodarczyk, Marcin Fabisiak, Natalia et al.

Source: Journal of Gastrointestinal & Liver Diseases. Dec2019, Vol. 28 Issue 4, p473-481. 10p.

Eosinophilic Esophagitis After Radiofrequency Ablation of Barrett's Esophagus in a 41-Year-Old Man.

Authors: Mokrowiecka, Anna Wróbel, Agata Fabisiak, Adam et al.

Source: American Journal of Case Reports. 10/6/2025, Vol. 26, p1-5. 5p.

Antinociceptive potency of enkephalins and enkephalinase inhibitors in the mouse model of colorectal distension—proof‐of‐concept.

Authors: Fabisiak, Adam Sobocińska, Małgorzata Kamysz, Elżbieta et al.

Source: Chemical Biology & Drug Design. Jul2018, Vol. 92 Issue 1, p1387-1392. 9p.

Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.

Authors: Fabisiak, Adam Włodarczyk, Jakub Fabisiak, Natalia et al.

Source: Journal of Neurogastroenterology & Motility. Jul2017, Vol. 23 Issue 3, p341-348. 8p.

The Expression of F2RL1, P2RX2, P2RX3 and P2RY2 in the Esophagus of Patients with Gastroesophageal Reflux Disease and Their Relationship to Reflux Symptoms—A Pilot Study.

Authors: Mokrowiecka, Anna Bartoszek, Adrian Fabisiak, Adam et al.

Source: Journal of Clinical Medicine. Mar2025, Vol. 14 Issue 6, p1884. 11p.

Clinical assessment of inflammatory bowel disease activity: a critical overview.

Authors: Fabisiak, Adam Murawska, Natalia Mokrowiecka, Anna et al.

Source: Journal of Medical Science. 2015, Vol. 84 Issue 2, p116-128. 13p.

Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment.

Authors: Dudek, Patrycja Fabisiak, Adam Zatorski, Hubert et al.

Source: Journal of Clinical Medicine. Dec2021, Vol. 10 Issue 23, p5660. 1p.

Possible application of trefoil factor family peptides in gastroesophageal reflux and Barrett's esophagus.

Authors: Fabisiak, Adam Bartoszek, Adrian Kardas, Grzegorz et al.

Source: Peptides. May2019, Vol. 115, p27-31. 5p.

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease.

Authors: Fabisiak, Adam Bartoszek, Adrian Talar, Marcin et al.

Source: Journal of Clinical Medicine. Dec2020, Vol. 9 Issue 12, p4111. 1p.

Purtscher’s-like retinopathy as a rare complication of acute alcoholic pancreatitis.

Authors: Wieczorek, Michalina M. Caban, Miłosz Fabisiak, Adam et al.

Source: Gastroenterology Review / Przegląd Gastroenterologiczny. 2021, Vol. 16 Issue 2, p170-173. 4p.

Association Between Temporomandibular Disorders and Irritable Bowel Syndrome: A Scoping Review.

Authors: Saczuk, Klara Roszuk, Sylwia Wirkijowska, Malgorzata et al.

Source: Journal of Clinical Medicine. Dec2024, Vol. 13 Issue 23, p7326. 11p.

Utility of Contrast-Enhanced Ultrasound in Optimizing Hepatic Abscess Treatment and Monitoring.

Authors: Dobek, Adam Kobierecki, Mateusz Kosztowny, Konrad et al.

Source: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5046. 12p.

Contrast-enhanced ultrasonography as a method of monitoring focal liver lesions - initial report.

Authors: Dobek, Adam Kobierecki, Mateusz Wieczorek, Patryk et al.

Source: Clinical & Experimental Hepatology. 2024, Vol. 10 Issue 2, p120-128. 9p.

Modulation of Gut Microbiota by Maillard Reaction Products in Intestinal Inflammation: Are We What We Eat?

Authors: Fabisiak, Adam¹ adam.fabisiak@stud.umed.lodz.pl

Source: Digestive Diseases & Sciences. Dec2017, Vol. 62 Issue 12, p3261-3262. 2p.

Usefulness of Contrast-Enhanced Ultrasound in the Differentiation between Hepatocellular Carcinoma and Benign Liver Lesions.

Authors: Dobek, Adam Kobierecki, Mateusz Ciesielski, Wojciech et al.

Source: Diagnostics (2075-4418). Jun2023, Vol. 13 Issue 12, p2025. 16p.

A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications.

Authors: Wołyniak, Maria Małecka-Wojciesko, Ewa Zielińska, Marta et al.

Source: Journal of Clinical Medicine. Nov2022, Vol. 11 Issue 22, p6675. 13p.